Genomics Guidances, Concept Papers, and MaPPs

The following listing includes FDA guidances, concept papers and operating procedures that deal with the development and application of genomic technologies in therapeutic and/or device development.  


1997FinalDrug Metabolism/ Drug Interaction Studies in the Drug Development Process: In Vitro (PDF - 109KB)CDER, CBER
2005FinalClass II Special Controls Guidance Document: Instrumentation for Clinical Multiplex Test Systems (PDF - 60KB) CDRH
2005FinalClass II Special Controls Guidance Document: CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Gene Mutation Detection Systems  [PDF version - 69KB]CDRH
2005FinalClass II Special Controls Guidance Document: Drug Metabolizing Enzyme Genotyping System  [PDF version - 72KB]CDRH
2005FinalPharmacogenomic Data Submission (PDF - 96KB)CDER, CBER, CDRH
2006DraftDrug Interaction Studies - Study Design, Data Analysis, and implications for Dosing and Labeling (PDF - 253KB)CDER, CBER
2007DraftPharmacogenomic Data Submission - Companion Guidance (PDF -211KB)CDER, NCTR, CBER, CDRH
2007FinalClass II Special Controls Guidance Document: Gene Expression Profiling Test System for Breast Cancer PrognosisCDRH
2007FinalPharmacogenomic Tests and Genetic Tests for Heritable Markers (PDF - 66KB)CDRH, CDER, CBER
2007DraftIn Vitro Diagnostic Multivariate Index Assays (PDF - 72KB)CDRH, CBER
2007FinalCommercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions (PDF - 139KB)CDRH, CBER
2009 DraftClinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products - Content and Format (PDF - 144KB) CDER, CBER 
2009 Final Drug-Induced Liver Injury: Premarketing Clinical Evaluation (PDF - 206KB) CDER, CBER  
2010Draft Adaptive Design Clinical Trials for Drugs and Biologics (PDF - 436KB) CDER, CBER 
2010Draft Qualification Process for Drug Development Tools (PDF -190KB) CDER 
2010DraftChronic Hepatitis C Virus Infection: Developing Direct-Acting Agents for Treatment (PDF - 306KB)CDER
2011DraftUse of Histology in Biomarker Qualification Studies (PDF -298KB)CDER
2011DraftIn Vitro Companion Diagnostic Devices (PDF - 134KB)CDRH
2012DraftEnrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products (PDF - 997KB)CDER, CBER, CDRH
2013FinalClinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies (PDF - 531KB)CDER, CBER, CDRH

 Concept Papers

 YearStatusTitle                       Center
2005Draft Drug-Diagnostic Co-Development Concept Paper (PDF - 479KB)                 FDA                    

 Manual of Policies and Procedures (MAPPS) 


Page Last Updated: 04/17/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English